In syngeneic mouse models, chimeric antigen receptor (CAR) T cells directed against FRβ selectively eradicated FRβ+ TAMs, thereby reshaping the tumor microenvironment toward a pro-inflammatory state, with enhanced monocyte influx, recruitment of endogenous CD8+ T cells, delayed tumor progression, and prolonged survival. The gene discussed is CD8A; the disease is neoplasm.